Clinical Trial Update: Paroxetine Safety and Efficacy in Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

An ongoing Phase 3 trial is evaluating paroxetine for safety and efficacy in rheumatoid arthritis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Mostafa Bahaa | Conditions: Rheumatoid Arthritis | Phase 3 | Status: RECRUITING